Skip to main content

Table 2 Node vulnerabilities

From: Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer

Node Vulnerability (%)
1 6.25
2 6.25
3 6.25
4 6.25
5 6.25
6 6.25
7 24.98
8 6.25
9 6.25
10 24.98
11 24.98
12 24.98
13 24.98
14 12.47
15 12.47
16 6.25
17 6.25
18 6.25
19 1.57
20 1.57
21 1.57
22 1.57
23 1.57
24 24.98